This inventor holds 9 USPTO granted patents and 6 published patent applications and 2 EPO patents. Top assignees: The Cleveland Clinic Foundation, University of Montana, The University of Texas System. Active years: 2012-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cleveland, OH (US) (2016)
- Missoula, MT (US) (2012 - 2022)
Company Filing History:
4 out of 1,074 
3 out of 69 
2 out of 5,638 
Years Active: 2012-2022
Title: Spotlight on Inventor Philippe Diaz: Pioneering Innovations in Therapeutics and Calcium Channel Modulators
Introduction:
In the diverse landscape of inventors and innovators, Philippe Diaz certainly stands out with his impressive contributions to scientific advancements. Hailing from Missoula, MT in the United States, Diaz has made significant strides in the field of therapeutic agents and calcium channel modulators. With a total of nine patents to his name, he has made notable contributions to the scientific community. Let's take a closer look at his latest patents, notable collaborations, and his association with companies.
Latest Patents:
Diaz's recent patents truly showcase his ingenuity and dedication to medical advancements. The first patent, entitled "Modified Carbazoles as Therapeutic Agents," focuses on compounds that target microtubules, offering valuable pharmaceutical compositions and methods of treating diseases affected by microtubule disruption. This research carries immense potential for treating a wide array of diseases within the medical field.
Additionally, Diaz's patent on "T-Type Calcium Channel Modulator and Uses Thereof" emphasizes his expertise in the field. This invention explores T-type calcium channel modulators, providing novel methods of producing and utilizing them for therapeutic purposes. The potential applications of this breakthrough include the treatment of various medical conditions related to calcium channel dysregulation.
Collaborations:
Philippe Diaz has collaborated with several accomplished researchers throughout his career. Two noteworthy cohorts include Mohamed Naguib Attala and Gerald Werner Zamponi. Together, they have undoubtedly amplified the impact of their research efforts.
Companies:
Diaz has contributed his expertise to several prestigious institutions and organizations. Among these, he has worked with UTI Limited Partnership, a company renowned for its commitment to innovation. His association with the University of Montana underscores his involvement in academia and the cultivation of knowledge through research and teaching.
Conclusion:
Philippe Diaz's contributions to the development of therapeutic agents and calcium channel modulators have undoubtedly made a significant impact in their respective fields. His dedication to improving the treatment of diseases and advancing medical research is commendable. By actively collaborating with esteemed scientists and institutions, Diaz continues to push the boundaries of innovation. We eagerly anticipate further breakthroughs from this visionary inventor.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile